Laux V - Search Results

1

A role for coagulation factor Xa in experimental pulmonary arterial hypertension.

Delbeck M, Nickel KF, Perzborn E, Ellinghaus P, Strassburger J, Kast R, Laux V, Schäfer S, Schermuly RT, von Degenfeld G. Delbeck M, et al. Among authors: laux v. Cardiovasc Res. 2011 Oct 1;92(1):159-68. doi: 10.1093/cvr/cvr168. Epub 2011 Jun 15. Cardiovasc Res. 2011. PMID: 21676958

2

Preclinical and clinical characteristics of rivaroxaban: a novel, oral, direct factor Xa inhibitor.

Laux V, Perzborn E, Kubitza D, Misselwitz F. Laux V, et al. Semin Thromb Hemost. 2007 Jul;33(5):515-23. doi: 10.1055/s-2007-982083. Semin Thromb Hemost. 2007. PMID: 17629849 Review.

3

Rivaroxaban: a new oral factor Xa inhibitor.

Perzborn E, Roehrig S, Straub A, Kubitza D, Mueck W, Laux V. Perzborn E, et al. Among authors: laux v. Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):376-81. doi: 10.1161/ATVBAHA.110.202978. Epub 2010 Feb 5. Arterioscler Thromb Vasc Biol. 2010. PMID: 20139357 Review.

4

Thrombin has biphasic effects on the nitric oxide-cGMP pathway in endothelial cells and contributes to experimental pulmonary hypertension.

Nickel KF, Laux V, Heumann R, von Degenfeld G. Nickel KF, et al. Among authors: laux v. PLoS One. 2013 Jun 13;8(6):e63504. doi: 10.1371/journal.pone.0063504. Print 2013. PLoS One. 2013. PMID: 23785394 Free PMC article.

5

Effects of Rivaroxaban on Platelet Activation and Platelet-Coagulation Pathway Interaction: In Vitro and In Vivo Studies.

Perzborn E, Heitmeier S, Laux V. Perzborn E, et al. Among authors: laux v. J Cardiovasc Pharmacol Ther. 2015 Nov;20(6):554-62. doi: 10.1177/1074248415578172. Epub 2015 Apr 6. J Cardiovasc Pharmacol Ther. 2015. PMID: 25848131 Free PMC article.

6

Effects of rivaroxaban, acetylsalicylic acid and clopidogrel as monotherapy and in combination in a porcine model of stent thrombosis.

Becker EM, Perzborn E, Klipp A, Lücker C, Bütehorn U, Kast R, Badimon JJ, Laux V. Becker EM, et al. Among authors: laux v. J Thromb Haemost. 2012 Dec;10(12):2470-80. doi: 10.1111/jth.12033. J Thromb Haemost. 2012. PMID: 23083002 Free article.

7

Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor-induced hypercoagulability in vitro and in vivo.

Perzborn E, Heitmeier S, Buetehorn U, Laux V. Perzborn E, et al. Among authors: laux v. J Thromb Haemost. 2014 Jul;12(7):1054-65. doi: 10.1111/jth.12591. Epub 2014 Jun 19. J Thromb Haemost. 2014. PMID: 24766850 Free PMC article.

8

Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?

Laux V, Perzborn E, Heitmeier S, von Degenfeld G, Dittrich-Wengenroth E, Buchmüller A, Gerdes C, Misselwitz F. Laux V, et al. Thromb Haemost. 2009 Nov;102(5):892-9. doi: 10.1160/TH09-02-0134. Thromb Haemost. 2009. PMID: 19888525 Review.

9

Reversal of rivaroxaban anticoagulation by haemostatic agents in rats and primates.

Perzborn E, Gruber A, Tinel H, Marzec UM, Buetehorn U, Buchmueller A, Heitmeier S, Laux V. Perzborn E, et al. Among authors: laux v. Thromb Haemost. 2013 Jul;110(1):162-72. doi: 10.1160/TH12-12-0907. Epub 2013 May 2. Thromb Haemost. 2013. PMID: 23636219

10

Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro.

Perzborn E, Heitmeier S, Laux V, Buchmüller A. Perzborn E, et al. Among authors: laux v. Thromb Res. 2014 Apr;133(4):671-81. doi: 10.1016/j.thromres.2014.01.017. Epub 2014 Jan 21. Thromb Res. 2014. PMID: 24529498 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters